ARTICLE | Top Story
FDA accepts Lilly Icos NDA
August 31, 2001 7:00 AM UTC
The FDA accepted for review the NDA for Cialis, a phosphodiesterase-5 (PDE-5) inhibitor to treat erectile dysfunction, submitted by Lilly Icos, a joint venture between ICOS and Eli Lilly (LLY). The Ci...